Please login to the form below

Not currently logged in
Email:
Password:

commercialisation

This page shows the latest commercialisation news and features for those working in and with pharma, biotech and healthcare.

China approves Ironwood Pharma’s IBS treatment

China approves Ironwood Pharma’s IBS treatment

AstraZeneca '. primarily responsible' on commercialisation across the vast country. Tom McCourt, Ironwood's new president said: “Regulatory approval in China represents another important step in bringing linaclotide to millions of adult

Latest news

More from news
Approximately 0 fully matching, plus 443 partially matching documents found.

Latest Intelligence

  • Diagnosed Anywhere Diagnosed Anywhere

    In 2018, the FDA approved IDx-DR, the first autonomous, AI-based diagnostic system authorised for commercialisation in the US.

  • Deal Watch October 2018

    agreement for the development and commercialisation of a follow‐on insulin glargine product to Sanofi’s Lantus. ... the development, formulation and preclinical development and Gilead for the clinical development and commercialisation.

  • Stakeholder dialogue in Europe’s adaptive pathways pilot Stakeholder dialogue in Europe’s adaptive pathways pilot

    Matthew Bending is the head of HTA, Strategy &Communication, Commercialisation &Outcomes at ICON plc, with responsibility for a global team based in the US and Europe. ... For more information visit www.ICONplc.com/commercialisation.

  • Regeneron and Bluebird sign $100m cell therapies deal Regeneron and Bluebird sign $100m cell therapies deal

    At this point, Regeneron will have the right to opt-in to a co-development/co-commercialisation deal for certain collaboration targets, with 50/50 cost and profit sharing.

  • Bluebird Bio: on the cusp of a gene therapy revolution Bluebird Bio: on the cusp of a gene therapy revolution

    I think this is the first time ever where a biotech has its first four programmes all heading towards filing and commercialisation in such a short period of time – that’s

More from intelligence
Approximately 1 fully matching, plus 107 partially matching documents found.

Latest appointments

  • Immunocore names new CEO, Nanoform adds to commercial team and Verona hires CMO Immunocore names new CEO, Nanoform adds to commercial team and Verona hires CMO

    Her appointment will significantly strengthen Immunocore as we advance our lead candidate, IMCgp100, towards commercialisation, and our growing pipeline of TCR candidates through clinical development.”.

  • BMS appoints new commercial leader, Davies joins Eisai and more BMS appoints new commercial leader, Davies joins Eisai and more

    His new role builds on his career history surrounding drug development through to commercialisation in both pharma and biotech industries.

  • Weekly industry appointments Weekly industry appointments

    Commenting on the new appointment, Keith Thompson, chief executive of CGT Catapult, said: “With over 20 years’ experience in R&D, Jonathan has both commercialisation and drug development expertise. ... be a global leader in the development and

  • Gamida Cell strengthens leadership team Gamida Cell strengthens leadership team

    Their combined experience in corporate strategy, business development and commercialisation will be invaluable to the company’s continued growth as we advance our clinical programmes in blood cancers and rare genetic

  • Abeona Therapeutics names CEO Abeona Therapeutics names CEO

    Steven Rouhandeh, executive chairman of Abeona, said: “As CEO, Carsten Thiel brings a unique combination of extensive experience in research and global rare disease commercialisation to Abeona.

More from appointments
Approximately 0 fully matching, plus 119 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 3 fully matching, plus 26 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Lucid Group Communications Limited

WE’RE ON A MISSION To enhance patients’ lives through communication that changes behaviour and improves patient health outcomes....

Latest intelligence

Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....

Infographics